From: Opiate agonist treatment to improve health of individuals with opioid use disorder in Lebanon
3-month assessment (n = 75) | 12-month assessment (n = 36) | ||||||||
---|---|---|---|---|---|---|---|---|---|
Variable and group | Baseline | Post 3 months | p value | Effect size | Baseline | Post 3 months | Post 12 months | p value | Effect size |
EUROHIS Quality of Life Scale (8–40) mean (s.d.) | 21.82 (6.59) | 24.93 (6.32) | p ≤ 0.001 | Cohen’s d = 0.37 | 22.37 (6.22) | 24.16 (5.82) | 24.84 (6.92) | p = 0.05 | η 2 = 0.14 |
Anxiety (HADS) (0–21) mean (s.d.) | 9.62 (4.09) | 7.29 (4.55) | p = 0.001 | Cohen’s d = 0.34 | 9.27 (3.84) | 7.18 (4.19) | 6.91 (3.91) | p = 0.006 | η 2 = 0.24 |
Depression (HADS) (0–21) mean (s.d.) | 8.97 (3.56) | 7.66 (3.69) | p = 0.03 | Cohen’s d = 0.21 | 8.94 (3.58) | 8.01 (3.54) | 7.65 (3.82) | p = 0.19 | η 2 = 0.17 |